Cancerify Logo
Log inSign up

Improving Outcomes for High-Risk Head and Neck Cancer with New Treatment Combinations

About This Trial

This trial looks at how well radiation therapy works when combined with different chemotherapy options and an immunotherapy drug after surgery in patients with high-risk head and neck cancer. The main goal is to find out if new treatment combinations can improve outcomes compared to the usual treatment. This includes comparing the effects of different drug combinations on the cancer.

NCT ID

NCT01810913

Study Details

RecruitingInterventionalPhase 2/Phase 3

Conditions

Oropharyngeal p16INK4a-Negative Squamous Cell CarcinomaStage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7Stage IV Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7

Eligibility

All sexesAdultOlder adult

Locations

AlabamaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMarylandMassachusettsMichiganMinnesotaMississippiMissouriNebraskaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsin